Polar Capital Holdings PLC Incyte Corp Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $26.1 Million - $32.1 Million	-500,000 Reduced 84.75%	90,000 $5.65 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $28.9 Million - $33 Million	-500,000 Reduced 45.87%	590,000 $34.1 Million
Q2 2023 Dec 13, 2023	SELL	$60.95 - $75.51 $609,500 - $755,100	-10,000 Reduced 0.91%	1,090,000 $67.9 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $609,500 - $755,100	-10,000 Reduced 0.91%	1,090,000 $67.9 Million
Q1 2023 Dec 13, 2023	BUY	$70.23 - $86.01 $35.8 Million - $43.9 Million	510,000 Added 86.44%	1,100,000 $79.5 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $9.49 Million - $11.6 Million	-135,072 Reduced 10.94%	1,100,000 $79.5 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $5.16 Million - $6.46 Million	76,774 Added 6.63%	1,235,072 $99.2 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $13.7 Million - $17.2 Million	207,258 Added 21.79%	1,158,298 $77.2 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $4.06 Million - $5.1 Million	-61,346 Reduced 6.06%	951,040 $72.3 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $33.5 Million - $40.4 Million	507,000 Added 100.32%	1,012,386 $80.4 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $238,665 - $279,246	3,768 Added 0.75%	505,386 $37.1 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $919,285 - $1.12 Million	-13,387 Reduced 2.6%	501,618 $34.5 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $19.1 Million - $20.9 Million	-239,000 Reduced 31.7%	515,005 $43.3 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $8.97 Million - $11.9 Million	118,000 Added 18.55%	754,005 $61.3 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $51.4 Million - $62.1 Million	636,005 New	636,005 $55.3 Million

Others Institutions Holding INCY

# of Institutions

651

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account